ROIV Stock Analysis: Buy, Sell, or Hold?
ROIV - Roivant Sciences Ltd. Common Shares
$29.50
0.28 (0.96%)
▲
5d:
+4.31%
30d:
+0.37%
90d:
+10.28%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: Jun 04, 2026
19d
Smart Money Accumulation
ROIV is down 8.1% this week, but smart money is accumulating calls. Top strike: $30 2026-06-18 with 21 OI. Call ratio: 91% View Scanner →
Strength: 8.2/10
Get Alerted When ROIV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ROIV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ROIV shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ROIV is currently trading at $29.50, which is considered extended relative to its 30-day fair value range of $27.93 to $29.24.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is approaching resistance at $29.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ROIV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.67 (+20.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ROIV is in a strong uptrend. The price is approaching resistance at $29.80. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: ROIV has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $35.67 (+20.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$27.93 -
$29.24
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.9% below Wall St target ($35.67)
Trading Range Analysis
30-Day Trading Range
$27.93 -
$29.24
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$27.52
Resistance Level
$29.80
Current Trend
Strong Uptrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.46
Wall Street Target
$35.67
(+20.9%)
Revenue Growth (YoY)
-77.8%
Earnings Growth (YoY)
-96.1%
Share & Embed Analysis
Last updated: May 15, 2026 1:33 AM ET
Data refreshes hourly during market hours. Next update: 2:33 AM
Data refreshes hourly during market hours. Next update: 2:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ROIV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Eric Venker
SELL
200000 shares
2026-04-20
Matthew Gline
SELL
289774 shares
2026-04-16
Jennifer Humes
SELL
13538 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 54 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 56 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$208 | 49 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$40 | 63 BUY |
Advanced ROIV Option Strategies
Professional options setups generated by AI based on today's ROIV price and gamma walls.
